Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 18.987% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCC(N)C12CC3CC(CC(O)(C3)C1)C2.Cl
[b] O=C(CNS(=O)(=O)c1ccccc1)OCC(=O)c1c[nH]c2ccccc12
[c] Cn1ccnc1C(=O)c1cc(SCC(=O)NC2CC2)nc2ccccc12
Answer: c. Cn1ccnc1C(=O)c1cc(SCC(=O)NC2CC2)nc2ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ccnc1C(=O)c1cc(SCC(=O)NC2CC2)nc2ccccc12
Cn1ccnc1C(=O)c1cc(SCC(=O)NC2CC2)nc2ccccc12
N-cyclopropyl-2-[4-(1-methylimidazole-2-carbonyl)quinolin-2-yl]sulfanylacetamide